E-mail: bd@sidmexinovia.com
Telefone: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pamorelin LA 11.25 mg Injection
Manufacturer/Marketed By : Dr Reddy'S Laboratories Ltd
$202.58 $149.59
Pamorelin LA 11.25 mg Injection is a powerful gonadotropin-releasing hormone (GnRH) agonist that plays a crucial role in hormone regulation, particularly within the reproductive system. This medication is primarily utilized...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Triptorelin 11.25 mg
Active Pharmaceutical Ingredient
Pamorelin LA 11.25 mg Injection
US$ 202,58
US$ 149,59
Pamorelin LA 11.25 mg Injection is a powerful gonadotropin-releasing hormone (GnRH) agonist that plays a crucial role in hormone regulation, particularly within the reproductive system. This medication is primarily utilized in the treatment of various conditions such as prostate cancer in men, breast cancer and endometriosis in women, and precocious puberty in children. By suppressing the secretion of certain hormones, Pamorelin effectively helps to manage these serious health issues, providing patients with a therapeutic option to improve their quality of life. While generally well-tolerated, it's essential for patients to be aware of potential side effects, including hot flashes and mood changes, and to discuss any pre-existing conditions or medications with their healthcare provider. Regular monitoring during treatment is recommended to ensure optimal results and to adjust dosages as necessary. As a reliable choice in hormone therapy, Pamorelin LA stands out for its ability to address complex medical needs while emphasizing patient safety and care. Always consult with a healthcare professional before starting treatment to ensure that Pamorelin is appropriate for your specific health situation.
Active Pharmaceutical Ingredient
Usos
• Pamorelin la 11 25 mg injection is utilized in the management of endometriosis, a condition characterized by the presence of endometrial tissue outside the uterus. This medication aids in alleviating the pain associated with endometriosis while also reducing the size of endometriotic lesions. By providing hormone suppression, Pamorelin la 11 25 mg injection helps to improve the quality of life for those affected. It is commonly prescribed to patients experiencing significant discomfort due to this condition.
• In cases of uterine fibroids, Pamorelin la 11 25 mg injection is administered prior to surgical intervention. This treatment is particularly beneficial for patients suffering from anemia due to heavy vaginal bleeding caused by fibroids. By suppressing hormone levels, Pamorelin la 11 25 mg injection can help stabilize the patient’s condition and enhance surgical outcomes. The therapy is typically limited to a three-month duration to prepare patients for surgery.
• Pamorelin la 11 25 mg injection is indicated for the treatment of advanced prostate cancer, offering an important therapeutic option for managing this condition. By reducing testosterone levels, which can fuel the growth of prostate cancer cells, this medication plays a crucial role in the overall treatment plan. Patients receiving Pamorelin la 11 25 mg injection may experience a decrease in cancer-related symptoms. This use underscores the importance of hormone modulation in the management of advanced prostate cancer.
• For children diagnosed with central precocious puberty (CPP), Pamorelin la 11 25 mg injection serves as a vital treatment option. This medication helps to delay the onset of secondary sexual characteristics, allowing for more appropriate physical and emotional development. Pamorelin la 11 25 mg injection is specifically designed to address the hormonal imbalances associated with CPP. Its role in managing this condition is crucial for ensuring healthy growth patterns in affected children.
Benefícios
In the treatment of endometriosis: Endometriosis is a condition where tissue such as the lining of the uterus starts to grow in other places. The main symptoms are pain in the lower abdomen or back, period pain, pain during and after sex, constipation, diarrhoea and nausea. It can also make it difficult to get pregnant. Pamorelin LA 11.25 mg Injection works by stopping the lining of your womb and any endometriosis tissue from growing too quickly. This will help to relieve any symptoms you may have. This medicine must be taken regularly to be effective and you may also need other medicines or procedures to help control your endometriosis. Treating uterine fibroids: Uterine fibroids are non-cancerous growths of the uterus that often appear during childbearing years. Pamorelin LA 11.25 mg can help control the symptoms associated with uterine fibroids, such as excessive menstrual bleeding and lower back pain, and also reduce the size of existing fibroids. It works by blocking the action of the enzyme responsible for fibroid growth. As a result, they shrink and stop growing. In the treatment of advanced prostate cancer: The prostate is a small gland about the size of a walnut that produces a fluid called seminal fluid that nourishes and carries sperm in men. The most common symptom of prostate cancer is difficulty urinating, but sometimes there are no symptoms at all. Pamorelin LA 11.25 mg Injection can reduce or stop the growth of cancer cells by reducing the amount of testosterone (a natural hormone in men) in men. This will also relieve urinary problems and make it easier to pass urine. To treat precocious puberty (early puberty): When puberty (the change of a child's body to adult structure and size) begins before the age of 8 in girls and before the age of 9 in boys, it is called precocious puberty. Pamorelin LA 11.25 mg helps delay this early onset of adulthood and limits the onset of precocious puberty. However, this medicine is only given by a doctor and should not be used unless you have it.
Efeitos colaterais
Like all medicines, Pamorelin LA 11.25 mg Injection may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Efeitos colaterais mais comuns
• Hot Flushes
• Impotence
• Dry Mouth
• Improper Sleep
• Pain in the Abdomen
• Pain in Legs, and Arms
• Excessive Sweating
• Headache
• Nose bleeding
• Bone and Muscle Pain
• Headache
• Impotence
Efeitos colaterais comuns
• Blisters
• High Fever
• Breath Shortness
• Vision Disturbance
• Inability of Taste
• Chest Pain
• Swelling in Joints
• Discolouration of the Skin
Como usar
Pamorelin LA 11.25 mg Injection is given through intravenous infusion under the skin. It is given by a qualified nurse or doctor in a hospital or a clinic.
Conselhos de segurança
• Alcohol: It is not recommended that you drink alcohol while taking Pamorelin LA 11.25 mg Injection. Alcohol may increase the risk of side effects or reduce the effectiveness of Pamorelin LA 11.25 mg. It is best to talk to your doctor or pharmacist before drinking alcohol while taking any medicine.
• Kidney: If you have kidney disease, please consult your doctor before taking Pamorelin LA 11.25 mg Injection. Your doctor will weigh up the benefits and potential risks before prescribing it.
• Breastfeeding: It is not recommended to breast-feed while taking Pamorelin LA 11.25 mg. It is possible that Pamorelin LA 11.25 mg Injection may pass into breast milk and harm the baby. If you are breastfeeding and taking Pamorelin LA 11.25 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor can help you make the best decision for you and your baby's health.
• Liver: If you have liver disease, please consult your doctor before taking Pamorelin LA 11.25 mg. Your doctor will weigh up the benefits and potential risks before prescribing it.
• Pregnancy: The use of Pamorelin LA 11.25 mg Injection during pregnancy may be unsafe as animal studies suggest that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Pamorelin LA 11.25 mg Injection during pregnancy. Your doctor can help you make the best decision for you and your baby's health.
• Driving: This Pamorelin LA 11.25 mg Injection can cause dizziness, drowsiness, and problems with concentration and coordination, which may affect your ability to drive safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving or operating heavy machinery if you are experiencing the side effects of this Pamorelin LA 11.25 mg.
Isenção de responsabilidade
A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.
Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.
Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.
Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.